Your browser doesn't support javascript.
loading
Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model.
Papaleo, Francesco; Yang, Feng; Paterson, Clare; Palumbo, Sara; Carr, Gregory V; Wang, Yanhong; Floyd, Kirsten; Huang, Wenwei; Thomas, Craig J; Chen, Jingshan; Weinberger, Daniel R; Law, Amanda J.
Afiliação
  • Papaleo F; Clinical Brain Disorders Branch, Genes, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, Department of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia, via More
  • Yang F; Clinical Brain Disorders Branch, Genes, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, Lieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore,
  • Paterson C; University of Colorado, School of Medicine, Department of Psychiatry, Aurora, Colorado 80045.
  • Palumbo S; Clinical Brain Disorders Branch, Genes, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, Laboratory of Molecular Biology, Department of Surgical, Medical and Molecular Pathology and
  • Carr GV; Clinical Brain Disorders Branch, Genes, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, Laboratory of Molecular Biology, Department of Surgical, Medical and Molecular Pathology and
  • Wang Y; Clinical Brain Disorders Branch, Genes, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, Lieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore,
  • Floyd K; University of Colorado, School of Medicine, Department of Psychiatry, Aurora, Colorado 80045.
  • Huang W; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland 20850.
  • Thomas CJ; National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland 20850.
  • Chen J; Clinical Brain Disorders Branch, Genes, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892.
  • Weinberger DR; Clinical Brain Disorders Branch, Genes, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, Lieber Institute for Brain Development, Johns Hopkins University Medical Campus, Baltimore,
  • Law AJ; Clinical Brain Disorders Branch, Genes, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, University of Colorado, School of Medicine, Department of Psychiatry, Aurora, Colorado 80045
J Neurosci ; 36(17): 4859-75, 2016 04 27.
Article em En | MEDLINE | ID: mdl-27122041
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Neuregulina-1 / Modelos Animais de Doenças / Neurofisiologia Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Neuregulina-1 / Modelos Animais de Doenças / Neurofisiologia Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article